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Abstract Children with chronic kidney disease (CKD) are
affected by cardiovascular complications, including distur-
bances in the intraventricular conduction system. Body
surface potential mapping (BSPM) is a non-invasive
method of assessing the cardioelectrical field. Our aim
was to investigate conduction disturbances in young CKD
patients using ventricular activation time (VAT) maps. Our
study comprised 22 CKD children (mean age: 13.1±
2.5 years) treated conservatively and 29 control patients.
For each child 12-lead electrocardiogram (ECG) readings
were taken, and blood pressure and serum concentrations of
iPTH, Pi, t-Ca, creatinine, Fe
+3, ferritin, and Hb, as well as
eGFR were measured. All children underwent registration
in the 87-lead BSPM system, and group-mean VAT maps
and a difference map, which presents statistically significant
differences between the groups, were created. The VAT map
distribution in CKD patients revealed abnormalities specific
to left anterior fascicle block. The difference map displays
the areas of intergroup VAT changes, which are of
discriminative value in detecting intraventricular
conduction disturbances. Intraventricular conduction
impairments in the left bundle branch may occur in children
with CKD. BSPM enables conduction disturbances in CKD
children to be detected earlier than using 12-lead ECG. The
difference map derived from the group-mean isochrone
maps precisely localizes the sites of disturbed conduction in
the heart intraventricular conduction system.
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Introduction
There are numerous cardiovascular complications of com-
pound pathogenesis that appear in children with conserva-
tively treated chronic kidney disease (CKD). The causes of
these complications can be metabolic, hemodynamic, toxic,
humoral or vascular. Clinical observations indicate the
importance of arranging effective treatment for cardiovas-
cular disorders and predicting a prospective course of the
disease [1].
In our previous investigations concerning pediatric
patients with CKD, disorders in the heart intraventricular
conduction system were discovered using isointegral maps
[2].
Body surface potential mapping (BSPM) is one of the
electrocardiographic methods applied in modern cardiac
diagnostics. It enables the detection of various heart
abnormalities, as shown by many investigators, including
Miyashita and Okano, and Green and Abildskov [3, 4].
Some reports have stated that BSPM is clinically useful in
the early and precise diagnosis of intraventricular conduc-
tion disturbances, owing to its superiority over standard 12-
lead ECG [5].
The BSPM technique is based upon simultaneous
registering of electrocardiographic signals from a multi-
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DOI 10.1007/s00467-011-1982-yelectrode body surface array. Electrodes cover the surface of
the thorax, which enhances the possibility of detecting local
events in the electrocardiographic field. The large number
of recording electrode sites results in higher sensitivity of
BSPM, giving it an advantage over standard ECG. The
results of BSPM examinations are displayed graphically in
the form of so-called “heart maps,” which comprise three
different types: isochrone, isopotential, and isointegral. The
first map reflects the propagation of the heart depolarization
over the thoracic surfaces in time, the second shows the
distribution of the instant heart potential over the thorax,
and the third type depicts resultant potential fluctuations
occurring within the given time intervals of the cardiac
cycle (area under the ECG curve).
In the present study we used isochrone maps, which
reflect the body surface distribution of ventricular activation
time (VAT) isolines. The isochrones are lines connecting all
sites of the myocardium that are activated at the same time,
and isochrone maps (or VAT maps) provide general
information about the ventricular activation sequence. The
distribution and values of isochrone maps precisely reflect
the time of ventricular activation propagation [3–5].
In order to extract divergences between the VAT maps of
the two groups examined, i.e., children with CKD and
children without CKD, a “difference map” was created.
The aim of the present study was to investigate possible
intraventricular conduction disturbances in young patients
with CKD using VAT maps.
Patients and methods
A group of22childrenwithCKD(mean age:13.1±2.5 years)
treated conservatively, were recruited to the study and
constituted Group S. These 22 children were subdivided
according to CKD progression, following the K/DOQI 2002
guidelines [6]. Of the study patients, 18 were at the third
stage of CKD and the remaining 4 were at the second stage.
The duration of third-stage CKD was 2.3–7.1 years (mean:
4.94±1.48 years), and the duration of second-stage CKD
was 0.9–5.0 years (mean: 2.71±1.17 years).
In the study group, several primary causes of CKD were
noted: chronic glomerulonephritis (13 patients), reflux
nephropathy (7 patients), and congenital anomalies of the
urinary tract: polycystic kidney disease and obstructive
uropathy (2 patients).
Seven of the CKD patients were treated with antihyper-
tensive drugs (calcium channel blockers, angiotensin-
converting enzyme [ACE] inhibitors, beta-blocker agents).
Five were treated with monotherapy (calcium channel
blockers or ACE inhibitors) and the remaining two with
combined therapy (calcium channel blockers with beta-
blockers or calcium channel blockers with ACE inhibitors).
The other drugs used in the therapy were: vitamin D3
analogues, vitamins C, B complex, and folic acid, as well as
iron and ranitidine hydrochloride or omeprazole.
All the patients with third-stage CKD were kept on
phosphate-poor diets (phosphate intake did not exceed 500–
800 mg/day) and were treated with compounds that bind
phosphate in the intestine (calcium carbonate in doses of
35–200 mg/kg/day). The doses of these therapeutic agents
were individualized, so that the serum concentration of
phosphate was between 4.5 and 5.52 mg/dl and calcium
was between 8.8 and 10.8 mg/dl. Dietary calcium intake
was defined as: 500–600 mg of elementary calcium per day.
In each CKD patient, 12-lead ECG examination was
carried out. No signs of conduction abnormalities were
observed on the ECG tracings from any of the patients.
For all CKD patients, the trans-chest echocardiographic
examination (ECHO) was made with Sonos 1000 apparatus
(Hewlett Packard), equipped with 3.0-MHz topographic
heads. It was found that the M-mode measurements of the
left ventricle (late diastolic and late systolic diameter,
interventricular wall, and left ventricle posterior wall
thickness) were within the normal ranges after adjusting
for the patients’ body mass. Thus, there were no cases of
left ventricle hypertrophy in the entire study population.
Also, the markers of overall contractility, i.e., ejection
fraction (EF) and shortening fraction (FS), indicated quite
normal systolic function of the left ventricle in all the
patients examined.
The control group (Group C) comprised 29 children (mean
age: 12.7±3.1 years) hospitalized because of nocturnal
enuresisand presentingno renal orcardiac clinicalsymptoms,
as well as showing normal arterial blood pressure values and
no abnormalities on ECG and ECHO findings.
In all patients, the following parameters were determined
in the serum: inorganic phosphate (PI), total calcium (t-Ca),
creatinine (cr), intact parathyroid hormone (iPTH), iron
(Fe
+3), ferritin, and hemoglobin (Hb). The estimated
glomerular filtration rate (eGFR) was calculated according
to the Schwartz formula [7]. Serum PI, and t-Ca were tested
by the direct potentiometry method, using ion-selective ISE
electrodes with the automatic analyzer Konelab (bioMérieux,
France) with the following reference ranges: Ca-t: 8.80–
10.80 mg/dl; PI:4 . 5 –5.52 mg/dl. Serum creatinine was
determined by the Jaffe method (reference range: 0.3–
1.0 mg/dl). iPTH was estimated by the immunoenzymatic
ELISA microassay of the solid phase from Roche Diagnostic
(Poland) on an Immulite 2000 apparatus (reference range:
11–67 pg/ml). The colorimetric method was used for
determination of serum iron (reference range 8.9–
21.4 μmol/l). Ferritin was tested by nefelometric methods
(reference range: 7–290 μg/l).
Table1 displays the selected demographic and biochemical
parameters taken from the study groups examined.
252 Pediatr Nephrol (2012) 27:251–259All study and control children were subjected to a
procedure of noninvasive recordings of electrocardiographic
signals with the use of the body surface potential mapping
(BSPM) method, giving a precise insight into the cardio-
electric field. BSPM registrations were performed in the 87-
lead HPM-7100 system (Fukuda Denshi, Tokyo, Japan) [8].
The electrode standardized array was applied using one-use
electrodes placed on 13 adhesive strips mounted in rows on
the anterior and posterior thoracic surfaces (designated on the
maps the letters A to M), as displayed in Fig. 1.
Using the raw electrocardiographic data obtained from
the ECG signals recorded simultaneously from the 87
electrode sites, maps presenting ventricular activation time
(VAT maps) were created. In the present study, VAT was
determined by a computer program at each thoracic lead as
the time taken from the onset of ventricular depolarization
(i.e., onset of the QRS complex) to the peak of the R wave.
In the next step, the difference map, which reflects the
statistically significant differences between the two group-
mean VAT maps (i.e., averaged for both control and patient
group), was established. Differences were calculated
through comparing the VAT values at each of the 87
electrode sites in the two group-mean isochrone maps.
The values of the difference map were obtained by
calculating differences of the averaged values of ventricular
activation time, taking into account the confidence interval
at a significance level α=0.05, at every recording site for
both of the groups examined. The procedure was applied
using EXCEL software. If the determined difference fell
within the confidence interval, meaning that it did not differ
significantly from zero, it was marked on the map as a null
value. Other difference values, positive or negative, were
significantly different from zero. Positive differences
express a delay in the electrocardiographic signal reaching
the measuring thoracic electrodes.
In addition to the quantity assessment mentioned above,
a quality evaluation of the two group-mean VAT maps was
performed by visual comparison of the distribution of the
isochrone lines on the maps.
The parents of all children enrolled in the present study
gave their informed consent to the procedures to be
performed. The investigation protocol was approved by
the local Bioethics Committee.
Table 1 displays data obtained from the comparisons
performed between the different groups using the non-
parametric Mann–Whitney U test for the same distribution
variables. A value of p<0.05 was considered to be
statistically significant.
Probability values of VAT at each of the 87 measuring
points were calculated using the Welch’s test (generalized
Student’s t test) and are presented in Table 2.
Table 1 Biochemical findings
in the groups examined
iPTH, intact parathormon; PI,
inorganic phosphate; t-Ca, total
calcium; cr, creatinine; eGFR,
glomerular filtration rate; BMI,
body mass index; Hb, hemoglo-
bin; Fe
+3, ferrum iron; Systolic
BP, systolic blood pressure;
Diastolic BP, diastolic blood
pressure; NS, not significant; p,
probability
Parameters C, control group S, study group p
n=29 n=22
Age (years) 12.7±3.1 13.1±2.5 NS
F/M 13/16 17/5 <0.05
BMI 20.59±1.03 19.05±2.82 <0.02
iPTH (pg/ml) 41.53±4.33 91.00±5.21 <0.001
PI (mEq/l) 4.87±0.31 5.01±0.45 NS
t-Ca (mg/dl) 9.65±0.71 10.02±0.34 <0.05
cr (mg/dl) 0.78±0.22 1.33±0.45 <0.001
Hb (g/dl) 13.96±0.64 13.71±0.74 NS
Fe
+3(μmol/l) 16.31±3.50 13.28±4.94 <0.04
Ferritine (μg/l) 119.11±14.08 115.38±37.61 NS
GFR (ml/min/1.73 m) >90 ml 45.00±9.00 ml <0.001
Systolic BP (mmHg) 121.18±4.34 121.45±10.27 NS
Diastolic BP (mmHg) 70.36±3.44 69.91±7.96 NS
Fig. 1 Scheme of electrodes placement on the thoracic surfaces
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In healthy individuals, ventricular activation starts from the
atrio-ventricular node, then proceeds via the His bundle
branches, right and left, and finally reaches the myocardium
through the Purkinje fibers (see Fig. 2).
On the VAT map averaged for the control children
(Group C), the shortest measurable activation time (from
1 to 17 ms) is observed in the upper and middle portions of
the anterior torso, along the mid-anterior line and adjacent
lines (D, E, G) as well as in the upper left back (between
the left posterior axillary line and the left scapular line).
The further isochrones of values up to 30 ms extend
backward, spreading quite evenly toward the left and right
parts of the thorax. Some of the isochrones on the left
thorax comprise its upper section and slowly migrate to the
back. Below that region, the range of isolines up to 40 ms
occurs. Then, in the interval time from 40 to 50 ms,
isochrone lines cover not only the lower right anterior
thorax, but also considerable areas of the thorax reaching
the left posterior scapular line.
In the next phase of activation propagation, lasting up to
60 ms, isochrones appear in the lower right anterior thorax,
reaching the right midaxillary line, and in the back from the
left posterior scapular line to, once again, the right
midaxillary line. The final time interval, up to 80 ms,
finishing the graphical representation of ventricular activa-
tion trajectory, takes place over the upper left back and
trespasses into the right upper anterior part of the thorax.
When analyzing the VAT map of healthy children, one
can see that the area of the heart activated at first is a
subendocardial layer of the left bottom surface of the
intraventricular septum and a small portion of the free wall
of the left ventricle. Then, the activation wave front
wanders from the left to the right side of the intraventricular
septum. In the next step, the activation extends over the
right septal surface and subendocardial surfaces of the right
and left ventricle free walls in the periapical region.
Subsequently, free ventricular walls are activated, but
within the left ventricle (because of its larger mass) this
process lasts longer. In the final phase of ventricular
depolarization, the wave front moves clearly upwards
reaching the basal sections of the heart, which is seen on
the VAT maps in the right portion of both the anterior and
posterior surfaces of the thorax.
In 18 out of 22 patients with CKD (Group S) the
distribution of isochrone lines in VAT maps differed from
the control map (Fig. 3).
In these cases the onset of ventricular activation is
observed in the area situated between the anterior mid-
sternal line and both right and left parasternal lines.
Isochrones appearing in the time interval up to 40 ms go
toward the bottom of the anterior thorax. Starting from
50 ms, on the left side isolines cross through the lower
anterior thorax to the left axillary line, whereas on the right
side, they reach to the right midclavicular line. Next,
isochrones wander upward, to the middle part of the back,
and on the right side come up to the right anterior axillary
line. In this zone, there are some delays in activation
propagation caused by disturbances in the left anterior
fascicle of the His bundle. Up to 80 ms, isochrones reach
the upper back as well the right anterior portion of the
thorax, which indicates the end of the ventricular depolar-
ization process.
The distribution of VAT maps, assessed both visually and
by comparing the VAT values at each of the measuring
Table 2 Distribution of proba-
bility values
NS, in those points, the mean
VAT values of the compared




A 0.001 0.001 0.001 0.001 0.001 0.001 0.001
B NS NS NS 0.001 0.001 0.001 0.001
C NS NS NS 0.001 0.001 0.001 0.001
D NS NS NS NS NS 0.001 0.001
E NS NS NS NS NS NS 0.001
F NS NS NS NS NS NS 0.001
G NS NS NS 0.001 0.001 0.001 0.001
H NS NS 0.001 0.001 0.001 0.001 0.001
I NS 0.001 0.001 0.001 0.001 0.001 0.001
J 0.001 0.001 0.001 0.001 0.001 0.001 0.001
K 0.001 0.001 0.001 0.001 0.001 0.001 0.001
L 0.001 0.001 0.001 0.001 0.001 0.001 0.001
M 0.001 0.001 0.001 0.001 0.001 0.001 0.001
A 0.001 0.001 0.001 0.001 0.001 0.001 0.001
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concordant with the pattern map previously established in
our laboratory for cases with clinically diagnosed left
anterior fascicular block of the His bundle (LAFB). As
was seen on VAT maps taken from those CKD patients, the
earliest ventricular depolarization, as in normal children,
occurs in the subendocardial layer of the left lower
intraventricular septum. Then, the activation wave front
turns through the intraventricular septum from left to right.
At that time, in the right parasternal region, short-term R
waves appear. Up to 30 ms, the activation state comprises
the right surface of the intraventricular septum as well as
the subendocardial layer of the free wall of the right
ventricle. Because of LAFB, the free wall of the left
ventricle is depolarized with a delay, using a collateral
pathway conducting through the posterior fascicle of the
bundle of His. In the final stage, the activation wave front
reaches the anterior and lateral segments of the left
ventricle, and then, still directing to the left, upward, and
backward, comprises the remaining portions of the free wall
of the left ventricle.
It is worth noting that the four remaining patients with
CKD whose VAT maps showed physiological intraventric-
ular conduction were at the second stage of CKD and
presented relatively high eGFR values (range: 65.5±
3.69 ml/min/1.73 m
2).
Application of the map of statistically significant differ-
ences makes it possible to compare distributions of the
group-mean VAT maps taken from the two groups being
examined, i.e., children with CKD treated conservatively
and normal children. The difference map displays graph-
ically the areas of discriminative divergence between the
two group-mean VAT maps obtained from the two groups
under consideration.
Analysis of the difference map revealed that both for the
LAFB cases and for the control group, the first part of the
ventricular activation trajectory up to the bundle division,
as reflected on the VAT maps, is comparable; hence, there
Fig. 2 Ventricular activation
time (VAT)-mean map from the
control children (C group). a On
plane; 3-dimensional view
Pediatr Nephrol (2012) 27:251–259 255was a lack of significant differences in an extensive region
of the entire lower anterior, middle, and posterior thorax
(Fig. 4).
In turn, ventricular activation time measured in the upper
regions, from the right midclavicular line through the left
axillary line, up to the right scapular line, is significantly
prolonged in CKD cases, compared with the corresponding
region in the control group. Isolines of values from 10 ms
to 50 ms travel upward to the middle part of the back. The
isoline with the highest value of 62 ms appears at the
electrodes J7 and K7 located in the left portion of the
thorax.
Probability values of VAT at each of the 87 measuring
points are presented in Table 2.
Taking into consideration the biochemical findings, in
children with CKD, the serum iPTH concentration
showed a statistically significant increase compared with
the controls (p<0.001). As for inorganic phosphate, its
mean level was within the normal range for all the study
children, although an insignificant tendency for the higher
values in the CKD children was observed. Calcium ions
also generally fell within the normal laboratory range, but
in the CKD patients Ca
+2 levels turned out to be
significantly lower than in the control subjects (p<0.05).
Discussion
Chronic kidney disease in children can lead to impairments
in the cardiovascular system [9, 10]. One of the constant
components of these changes is disturbances in depolariza-
tion propagation within the intraventricular conduction
system. Metabolic abnormalities, including increased ure-
mic toxemia, can be a reason, as well as some conduction
alterations caused by various cardiac conditions, like left
ventricle hypertrophy, cardiomyocytes degeneration, calci-
fication of the myocardium, and changes in vascular
architecture [11].
Kozlíková et al., using the 32-electrode BSPM system,
established a pattern of isochrone maps for a population of
Fig. 3 VAT-mean map from the
children with chronic kidney
disease (CKD) treated conser-
vatively (S group) displaying a
pattern of early left anterior
fascicle block. a On plane;
b 3-dimensional view
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accordance with our data from the 87-lead system,
confirmed that under physiological conditions electrical
impulses propagate to both ventricles through the atrio-
ventricular node, the bundle of His, with its right and left
branches, and finally via the Purkinje fibers to the
myocardium.
Based on the distributions of the VAT maps obtained in
our study, it was found that isochrones in children with
CKD treated conservatively behaved in a different manner
than in normal subjects. The conduction pathway seemed to
be initially quite normal until it reached a region in the left
anterior fascicle of the His bundle. In the further stages of
activation propagation some delay of conduction was noted
on the left side of the anterior thorax. This kind of
conduction disturbance can lead to delayed depolarization
of the left ventricle, which results in hemodynamic
dyssynchrony and deteriorating systolic function of the
heart [13, 14].
The above-described impairments yield a pattern of
LAFB, which is a consequence of disturbances in this
specific portion of the intraventricular conduction system.
In such cases, the activation wave front is compelled to
avoid the obstacle and proceeds at first through the
posterior fascicle of the His bundle. This results in a
slowing down of the depolarization process of both the
anterior and lateral segments of the left ventricle, which are
physiologically activated by the anterior fascicle [15].
Analyzing the isochrone map distributions, we observed
changes suggesting LAFB in 18 out of 22 patients (88%)
with CKD who were treated conservatively. Only in the 4
remaining patients did the VAT maps present normal
Fig. 4 Difference map: map
presenting the significant differ-
ences in the mean VAT values
between the patient group and
the control group. a On plane; b
3-dimensional view
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intraventricular conduction.
Early and slight disturbances in the heart intraventricular
conduction can be non-invasively detected only with a
multielectrode recording system, like BSPM. BSPM has
been shown to be the only non-invasive method of
assessing the cardioelectric field from signals collected on
the body surface, which is of higher sensitivity and
specificity compared with the standard 12-lead ECG
examination [16].
It is assumed that in patients with CKD numerous
cardiovascular disorders are induced mainly by arterial
hypertension and secondary hyperparathyroidism [9]. In
fact, a significant increase in serum iPTH was found in our
study group with CKD, compared with the control group
(91.00±5.21 vs 41.53±4.33; p<0.001).
Considerable long-standing hypersecretion of intact
parathyroid hormone could account for changes occurring
in the intraventricular conduction system in CKD patients.
iPTH is commonly considered one of the most serious
uremic toxins. Elevated iPTH level may be a cause of
calcification of coronary arteries. Relationships between
serum iPTH levels and arteriosclerotic changes both in vivo
and in vitro have been demonstrated [17, 18]. Furthermore,
increased iPTH concentration results in enhanced influx of
Ca
2+ ions into the cell cytoplasm and subsequent damage to
mitochondria, which can result in dysfunction of the heart
conduction system [19].
On the other hand, significantly lower total Ca
+2 serum
concentrations were found in our study patients (9.65±0.71
vs 10.02±0.34; p<0.05). It is known that hypocalcamia can
lead to improper muscle contraction and distorted trans-
mission of electrical impulses in cardiomyocytes [18, 19].
Calcium depletion compromises membrane calcium chan-
nel activity and inward flow of calcium ions to cardiomyo-
cytes, which is prerequisite for the upstroke of the action
potential and proper depolarization progress in the heart
[20]. According to some investigators (e.g., Mitsnefes et
al.), increased serum phosphate concentrations can also
cause pathological alterations in the cardiovascular system
[21]. However, in our study such contributions cannot be
considered a pathomechanism of intraventricular conduc-
tion abnormalities, since no significant differences in
phosphate levels were noted between the CKD patients
and the control group.
A novel approach presented in our study was the use of a
difference map showing significant differences between the
VAT maps averaged for the groups of children examined:
healthy subjects and CKD patients. The difference map, in
a simple and quick visual manner, enables the assessment
of the areas in which VAT values are delayed in relation to
those established for the controls. In addition, this statistical
technique facilitates recognition of precise sites of activa-
tion propagation blockage within the heart’s intraventricular
conduction system.
Progression in the clinical course of CKD inevitably
leads to serious heart conduction impairments as well as left
ventricle hypertrophy and heart failure [22]. The difference
map turned out to enhance the areas of intergroup VAT
changes, which are of discriminative value in detecting
intraventricular conduction disturbances. Therefore, the
study children with CKD, in whom intraventricular con-
duction disturbances were diagnosed with BSPM, could be
referred for early cardiac supervision.
Summing up, the results of our study suggest that
BSPM, with its high sensitivity, enables early detection of
intraventricular conduction abnormalities, which are not
seen on the routine ECG. This allows us to perform a
stratification of CKD patients and provide them with
adequate management, in order to protect them from severe
cardiac complications.
Conclusions
1. Intraventricular conduction system impairments within
the left bundle branch may occur in children with
moderate CKD.
2. BSPM enables the detection of heart conduction
disturbances in children with CKD earlier than 12-
lead ECG.
3. The difference map derived from the isochrone group-
mean maps precisely localizes the sites of disturbed
conduction in the heart’s intraventricular system.
Disclosure None of the authors declared any competing interests.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Wu-Wong JR (2009) Potential for vitamin D receptor agonists in
the treatment of cardiovascular disease. Br J Pharmacol 158:395–
412
2. Polak-Jonkisz D, Laszki-Szcząchor K, Purzyc L, Zwolińska D,
Musiał K, Pilecki W, Rusiecki L, Janocha A, Kałka D,
Sobieszczańska M (2009) Usefulness of body surface potential
mapping for early identification of the intraventricular conduction
disorders in young patients with chronic kidney disease. J
Electrocardiol 42:165–171
3. Miyashita T, Okano Y (1995) Isochrone map, its implication and
clinical usefulness. Nippon Rinsho 1:48–55
258 Pediatr Nephrol (2012) 27:251–2594. Green LS, Abildskov JA (1995) Clinical application of body
surface potential mapping. Clin Cardiol 18:24
5. Katayama K, Kamakura S, Shimomura K (1995) Relationship
between prognosis and electrocardiographic characteristic in
patients with left bundle branch block. Nippon Rinsho 1:132–
138
6. National Kidney Foundation (2008) K/DOQI clinical practice
guidelines for chronic kidney disease: evaluation, classification,
and stratification. Am J Kidney Dis 39:S1–S266
7. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma
creatinine concentration for estimating glomerular filtration rate in
infants, children and adolescents. Pediatr Clin North Am 34:488–
493
8. Fukuda Denshi Co. Ltd (1990) Heart potential mapping system.
Fukuda Denshi Co. LTD Bulletin, Tokyo
9. Chavers BM, Li S, Collins AJ, Herzog CA (2002) Cardiovascular
disease in pediatric chronic dialysis patients. Kidney Int 62:648–653
10. Scharer K, Schmidt KG, Soergel M (1999) Cardiac function and
structure in patients with chronic renal failure. Pediatr Nephrol
13:951–965
11. RobinsonRF,NahataMC,SparksE,DanielsC,BatiskyD,HayesJR,
Mahan J (2005) Abnormal left ventricular mass and aortic distensi-
bility in pediartic dialysis patients. Pediatr Nephrol 20:64–68
12. Kozlíková K, Hulín I, Kneppo P, Sapáková E, Bakosová M,
Molnárová Z (1993) Body surface isochrone maps of peak R in
normal adolescent girls. Physiol Res 42:99–102
13. Pastore CA, Tobias NM, Kaiser E, Samesima N, Martinelli FM,
Pedrosa A, Nishioka S, Siqueira S, Lourenco UR, Atanes LM,
Ramires JAF (2002) Electrocardiographic, vectocardiographic and
body surface potential mapping analyses of patients with
congestive heart failure and left bundle branch block, treated with
biventricular pacing. Int J Bioelectromagnetism 4:115–116
14. Potse M, Linnenbank AC, Grimbergen CA (2002) Software
design for analysis of multichannel intracardial and body surface
electrocardiograms. Comput Meth Programs Biomed 69:225–236
15. Fuster Siebert M, Castillo Sánchez J, Domińguez Sánchez R
(1980) Ventricular activation time at aVL and V6 leads in left
anterior hemiblock. Rev Esp Cardiol 33:573–579
16. Kornreich F, MacLeod RS, Lux RL (2008) Supplemented standard
12-lead electrocardiogram for optimal diagnosis and reconstruction
of significant body surface map patterns. J Electrocardiol 41:251–
256
17. Nakayama T, Ohtsuru A, Enomoto H, Namba H, Ozeki S, Shibata
Y, Yokota T, Nobuyoshi M, Ito M, Sekine I, Yamashita S (1994)
Coronary atherosclerotic smooth muscle cells overexpress human
parathyroid hormone-related peptides. Biochem Biophys Res
Commun 200:1028–1035
18. Jono S, Nishizawa Y, Shioi A, Morii H (1997) Parathyroid
hormonerelated peptide as a regulator of vascular calcification. Its
inhibitory action on in vitro calcification by bovine vascular
smooth muscle cells. Arterioscler Thromb Vasc Biol 17:1135–
1142
19. Rodriguez M, Lorenzo V (2009) Parathyroid hormone, a uremic
toxin. Semin Dial 22:363–368
20. Lipscombe D (2002) L-type calcium channels. High and new
lows. Circ Res 90:933–935
21. Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ,
Khoury PR, Daniels SR (2005) Cardiac and vascular adaptation in
pediatric patients with chronic kidney disease: role of calcium-
phosphorus metabolism. J Am Soc Nephrol 16:2796–2803
22. Mehta A, Jain AC, Mehta MC, Billie M (2000) Usefulness of
left atrial abnormality for predicting left ventricular hypertro-
phy in the presence of left bundle branch block. Am J Cardiol
85:354–359
Pediatr Nephrol (2012) 27:251–259 259